{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T19:50:34Z","timestamp":1794945034075,"version":"4.9.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jmii.2021.09.009","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T08:34:15Z","timestamp":1633768455000},"page":"1301-1309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"P2","title":["Clinical characteristics and outcomes of non-cystic fibrosis patients with Burkholderia cepacia complex bacteremia at a medical center in Taiwan"],"prefix":"10.1016","volume":"55","author":[{"given":"Tien-Hao","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann-Tay","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Huei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2021.09.009_bib1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3201\/eid1303.060403","article-title":"Environmental Burkholderia cepacia complex isolates in human infections","volume":"13","author":"Baldwin","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jmii.2021.09.009_bib2","first-page":"A3603","article-title":"A rare case of community acquired multi-drug resistant Burkholderia cepacia infection in an immune competent patient","volume":"197","author":"Gopalratnam","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2021.09.009_bib3","doi-asserted-by":"crossref","first-page":"A2525","DOI":"10.1016\/j.chest.2020.09.125","article-title":"A rare case of cepacia syndrome","volume":"158","author":"Khadka","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jmii.2021.09.009_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcf.2004.01.005","article-title":"Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults","volume":"3","author":"Courtney","year":"2004","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jmii.2021.09.009_bib5","first-page":"A3344","article-title":"The incidence and significance of post-operative bacteremia in pediatric cystic fibrosis lung transplant patients","volume":"191","author":"Mallory","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2021.09.009_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijantimicag.2017.07.004","article-title":"Clinical characteristics of bacteraemia caused by Burkholderia cepacia complex species and antimicrobial susceptibility of the isolates in a medical centre in Taiwan","volume":"51","author":"Chien","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2021.09.009_bib7","series-title":"Nelson textbook of pediatrics","first-page":"1529","article-title":"Pseudomonas, burkholderia, and stenotrophomonas","author":"Kliegman","year":"2019"},{"key":"10.1016\/j.jmii.2021.09.009_bib8","first-page":"730","article-title":"Management of cepacia syndrome with a combination of intravenous and inhaled antimicrobials in a non-cystic fibrosis pediatric patient","volume":"25","author":"Branstetter","year":"2020","journal-title":"J Pediatr Pharmacol Therapeut"},{"key":"10.1016\/j.jmii.2021.09.009_bib9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/01.ccm.0000551380.85134.d4","article-title":"Cepacia syndrome in rheumatoid arthritis-related interstitial lung disease","volume":"47","author":"Arora","year":"2019","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jmii.2021.09.009_bib10","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/cid\/cix559","article-title":"A 17-year nationwide study of burkholderia cepacia complex bloodstream infections among patients in the United States veterans health administration","volume":"65","author":"El Chakhtoura","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2021.09.009_bib11","first-page":"299","article-title":"Burkholderia cepacia complex outbreaks among non-cystic fibrosis patients in the intensive care units: a review of adult and pediatric literature","volume":"26","author":"Abdallah","year":"2018","journal-title":"Inf Med"},{"key":"10.1016\/j.jmii.2021.09.009_bib12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/519177","article-title":"Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case-control study","volume":"28","author":"Bressler","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jmii.2021.09.009_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jhin.2008.07.019","article-title":"Hospital outbreak of Burkholderia stabilis bacteraemia related to contaminated chlorhexidine in haematological malignancy patients with indwelling catheters","volume":"70","author":"Heo","year":"2008","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jmii.2021.09.009_bib14","first-page":"S369","article-title":"Outbreak of Burkholderia cenocepacia bacteraemia in an intensive care unit: an epidemiologic and molecular study","volume":"17","author":"Katsiari","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jmii.2021.09.009_bib15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bjid.2015.06.009","article-title":"Polyclonal outbreak of bacteremia caused by Burkholderia cepacia complex and the presumptive role of ultrasound gel","volume":"19","author":"Nannini","year":"2015","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jmii.2021.09.009_bib16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ajic.2012.04.325","article-title":"An outbreak of Burkholderia cepacia bacteremia in hospitalized hematology patients selectively affecting those with acute myeloid leukemia","volume":"41","author":"Vardi","year":"2013","journal-title":"Am Infect Control"},{"key":"10.1016\/j.jmii.2021.09.009_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13256-020-02415-8","article-title":"Investigation of Burkholderia cepacia complex bacteremia outbreak in a neonatal intensive care unit: a case series","volume":"14","author":"Bharara","year":"2020","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jmii.2021.09.009_bib18","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3109\/00365548.2011.589076","article-title":"Risk factors for mortality in patients with Burkholderia cepacia complex bacteraemia","volume":"43","author":"Ku","year":"2011","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jmii.2021.09.009_bib19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.diagmicrobio.2011.01.008","article-title":"Clinical characteristics and outcomes of patients with Burkholderia cepacia bacteremia in an intensive care unit","volume":"70","author":"Liao","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2021.09.009_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0255-0857.76516","article-title":"Burkholderia cepacia complex: beyond pseudomonas and acinetobacter","volume":"29","author":"Gautam","year":"2011","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.jmii.2021.09.009_bib21","doi-asserted-by":"crossref","first-page":"S775","DOI":"10.1093\/ofid\/ofz360.1943","article-title":"Clinical outcomes with single vs. combination antibiotic therapy in the treatment of burkholderia cepacia complex bacteremia and pneumonia","volume":"6","author":"George","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jmii.2021.09.009_bib22","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijantimicag.2008.09.010","article-title":"Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systematic review of the clinical evidence","volume":"33","author":"Avgeri","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2021.09.009_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/00365549950163608","article-title":"Endemic burkholderia cepacia bacteraemia: clinical features and antimicrobial susceptibilities of isolates","volume":"31","author":"Yu","year":"1999","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jmii.2021.09.009_bib24","series-title":"Performance standards for antimicrobial susceptibility testing: 30th informational supplement, M100S","year":"2020"},{"issue":"6","key":"10.1016\/j.jmii.2021.09.009_bib25","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jmii.2014.07.008","article-title":"Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy","volume":"48","author":"Tsai","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"10.1016\/j.jmii.2021.09.009_bib26","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/ckj\/sfy138","article-title":"Fast and furious: a retrospective study of catheter-associated bloodstream infections with internal jugular nontunneled hemodialysis catheters at a tropical center","volume":"12","author":"Agrawal","year":"2019","journal-title":"Clin Kidney J"},{"issue":"3","key":"10.1016\/j.jmii.2021.09.009_bib27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jmii.2015.07.001","article-title":"Central line-associated bloodstream infections among critically-ill patients in the era of bundle care","volume":"50","author":"Lin","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"issue":"10","key":"10.1016\/j.jmii.2021.09.009_bib28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s10096-003-0999-y","article-title":"Persistent bacteremia in the absence of defined intravascular foci: clinical significance and risk factors","volume":"22","author":"Chowers","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.jmii.2021.09.009_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/jmps.1999.1277","article-title":"Akaike's information criterion and recent developments in information complexity","volume":"44","author":"Bozdogan","year":"2000","journal-title":"J Math Psychol"},{"issue":"11","key":"10.1016\/j.jmii.2021.09.009_bib30","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s10096-020-03960-2","article-title":"Management and outcomes of Burkholderia cepacia complex bacteremia in patients without cystic fibrosis: a retrospective observational study","volume":"39","author":"Lee","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2021.09.009_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13082","article-title":"Successful ceftazidime-avibactam treatment of post-surgery Burkholderia multivorans genomovar II bacteremia and brain abscesses in a young lung transplanted woman with cystic fibrosis","volume":"21","author":"Dacc\u00f2","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jmii.2021.09.009_bib32","doi-asserted-by":"crossref","first-page":"e02213","DOI":"10.1128\/AAC.02213-17","article-title":"Successful treatment of persistent Burkholderia cepacia complex bacteremia with ceftazidime-avibactam","volume":"62","author":"Tamma","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118221001985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118221001985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:28:43Z","timestamp":1761658123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118221001985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1684118221001985"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2021.09.009","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and outcomes of non-cystic fibrosis patients with Burkholderia cepacia complex bacteremia at a medical center in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2021.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}